VEGFB and diabetic kidney disease: Inhibition of VEGF-B signal transduction in DKD mice attenuates renal lipotoxicity, resensitizes podocytes to insulin signal transduction, which hinders the progression of DKD-associated pathologies, and leads to the prevention of renal dysfunction (Falkevall et al., 2017[10]).